BPC-157 NASAL SPRAY 5MG: 50MCG PER SPRAY

Description

Legal Disclaimer
This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. BPC-157 is not approved for medical use, human consumption, or as a therapeutic treatment in this context.

Product Details

• Total Peptide Content: 5mg per nasal spray unit

• Delivery Format: Metered nasal spray

• Peptide Concentration: 50mcg per spray

• Estimated Sprays per Unit: ~100 sprays (device-dependent)

• Form: Aqueous peptide solution

• Packaging: Secure, sealed, tamper-evident nasal spray bottle

• Source: High-quality lab-grade peptide, independently third-party tested

• Purity: ≥98% (peptide content verified prior to formulation)

• Note: Intended strictly for controlled laboratory and experimental research applications

Overview of BPC-157 Nasal Spray’s Research Profile

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide originally derived from a protective protein sequence found in gastric tissue. In a nasal spray formulation, BPC-157 is studied for its potential role in systemic peptide signaling, tissue communication pathways, and non-invasive peptide delivery mechanisms within controlled research environments.

The intranasal format allows researchers to explore alternative peptide delivery routes and assess how small bioactive peptides interact with neural, vascular, and connective tissue signaling systems. BPC-157 is widely examined for its involvement in angiogenic signaling, cell survival pathways, and structural integrity signaling across multiple experimental models.

Research Specifics

BPC-157 nasal spray has been investigated in non-clinical research for its involvement in:

• Angiogenic Signaling Pathways
  Studies examining peptide-mediated vascular signaling and endothelial response mechanisms.

• Cellular Protection & Survival Models
  Research into peptide influence on oxidative stress resistance and cellular resilience pathways.

• Connective Tissue Signaling Research
  Evaluation of peptide-regulated communication within tendon, ligament, and extracellular matrix systems.

• Intranasal Peptide Delivery Studies
  Investigation of nasal administration as a route for systemic and central peptide distribution.

• Peptide Stability & Transport Analysis
  Assessing aqueous peptide formulation stability and delivery consistency.

Key Features

• Peptide Class: Pentadecapeptide (15 amino acids)

• Amino Acid Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

• Molecular Weight: ~1419 Da

• Delivery Method: Metered intranasal spray

• Per-Spray Output: 50mcg BPC-157

• Total Content: 5mg per unit

• Purity: ≥98% research-grade peptide

• Laboratory Stability: Formulated for stability in aqueous solution under appropriate storage conditions

Potential Applications

Researchers may explore BPC-157 nasal spray in studies involving:

• Angiogenesis and vascular signaling research

• Cellular protection and oxidative stress modeling

• Connective tissue communication pathways

• Intranasal peptide delivery system evaluation

• Multi-system peptide signaling investigations

Specifications

This product is supplied as a sealed, tamper-evident nasal spray unit to preserve peptide integrity and dosing consistency. The metered spray mechanism ensures uniform peptide delivery per actuation. Store under recommended refrigerated conditions to maintain stability.